Allergies, Rhinoconjunctivitis
Conditions
Keywords
Rhinoconjunctivitis due to house dust mite allergy
Brief summary
The purpose of the study is to test whether vaccinations with CYT003-QbG10 can improve allergy symptoms in patients with house dust mite allergy. The active treatment will be compared against placebo.
Interventions
DRUGCYT003-QbG10
subcutaneous injection
DRUGPlacebo
subcutaneous injection
Sponsors
Cytos Biotechnology AG
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Perennial allergic rhinoconjunctivitis due to clinically relevant allergy towards house dust mite allergens * Further criteria as defined in the study protocol
Exclusion criteria
* Clinically manifested seasonal allergy/-ies which is/are expected to interfere with the patient's study treatment schedule and/or assessments * Clinically relevant perennial allergy/-ies other than house dust mites allergy * Contraindication to any study test or procedure * Further criteria as defined in the study protocol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rhinoconjunctivitis symptom and medication scores | Pre- / Post-Treatment |
Countries
Estonia, Germany, Greece, Latvia, Lithuania, Romania
Outcome results
None listed